ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,117,000 | +73.1% | 3,000,000 | 0.0% | 0.01% | +66.7% |
| Q1 2019 | $5,267,000 | -72.2% | 3,000,000 | -80.9% | 0.00% | -76.9% |
| Q4 2018 | $18,948,000 | -52.1% | 15,685,000 | -50.0% | 0.01% | +8.3% |
| Q3 2018 | $39,590,000 | -5.9% | 31,370,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $42,065,000 | – | 31,370,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 19,000,000 | $25,524,000 | 0.87% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $13,528,000 | 0.81% |
| LINDEN ADVISORS LP | 19,075,000 | $25,654,000 | 0.79% |
| CSS LLC/IL | 10,335,000 | $13,881,000 | 0.65% |
| Graham Capital Management, L.P. | 10,000,000 | $13,464,000 | 0.50% |
| Verition Fund Management LLC | 5,750,000 | $7,725,000 | 0.47% |
| SG Americas Securities, LLC | 120,000 | $16,121,000 | 0.14% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,000,000 | $6,707,000 | 0.09% |
| Nicholas Investment Partners, LP | 500,000 | $670,000 | 0.05% |
| DEUTSCHE BANK AG\ | 31,370,000 | $42,065,000 | 0.01% |